MENU

JANX Janux Therapeutics Forecast, Technical & Fundamental Analysis

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

JANX is expected to report earnings to rise 35.40% to -47 cents per share on November 10

Janux Therapeutics JANX Stock Earnings Reports
Q3'26
Est.
$-0.47
Q2'26
Missed
by $0.08
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.23
The last earnings report on August 06 showed earnings per share of -34 cents, missing the estimate of -27 cents. With 199.81K shares outstanding, the current market capitalization sits at 1.01B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XCH3.310.21
+6.77%
XCHG Limited
TPC84.400.42
+0.50%
Tutor Perini Corp
PYPL53.89-0.39
-0.72%
PayPal Holdings
JBIO14.18-0.17
-1.18%
Jade Biosciences Inc
ESP64.64-0.88
-1.34%
Espey Mfg & Electronics Corp

JANX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VIR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+2.23%
VIR - JANX
40%
Loosely correlated
+1.33%
URGN - JANX
38%
Loosely correlated
-1.10%
AVBP - JANX
37%
Loosely correlated
+0.82%
ORMP - JANX
36%
Loosely correlated
-1.26%
VTGN - JANX
36%
Loosely correlated
+0.34%
More
Janux Therapeutics (JANX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com